GRWD-5769

N/A

Report date: 2024/06/19 17:22:28
NME

Base Information

Drug NameGRWD-5769
Drug Alias NameGRWD5769GRWD-5769
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEndoplasmic Reticulum Aminopeptidase 1 inhibitors
TargetsEndoplasmic Reticulum Aminopeptidase 1
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustraliaUnited Kingdom +[5
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesGrey Wolf Therapeutics Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A